Cristina A. Camnasio

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis.

A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis.

Journal: Journal of medical cases

Published: November 26, 2025

Does the abdominal entry method in laparoscopy really matter? A network meta-analysis of rare events in randomized trials.

Does the abdominal entry method in laparoscopy really matter? A network meta-analysis of rare events in randomized trials.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: September 22, 2025

PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey.

PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey.

Journal: ESMO open

Published: August 20, 2025

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response.

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response.

Journal: ESMO open

Published: April 30, 2025

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study.

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study.

Journal: ESMO open

Published: April 29, 2025

Antenatal, pregnancy and delivery risk factors for infant cerebral palsy: an umbrella review of meta-analyses and systematic reviews.

Antenatal, pregnancy and delivery risk factors for infant cerebral palsy: an umbrella review of meta-analyses and systematic reviews.

Journal: American journal of obstetrics & gynecology MFM

Published: January 23, 2025

Antenatal, pregnancy and delivery risk factors for infant cerebral palsy: an umbrella review of meta-analyses and systematic reviews.

Antenatal, pregnancy and delivery risk factors for infant cerebral palsy: an umbrella review of meta-analyses and systematic reviews.

Journal: American journal of obstetrics & gynecology MFM

Published: January 23, 2025

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study.

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study.

Journal: ESMO open

Published: November 10, 2024

Menopause and endometriosis.

Menopause and endometriosis.

Journal: Maturitas

Published: March 30, 2024

Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status.

Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status.

Journal: Gynecologic oncology

Published: February 04, 2024

Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience.

Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience.

Journal: Diagnostics (Basel, Switzerland)

Published: November 17, 2022

Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis.

Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 02, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026